Publication:
Physicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study

dc.contributor.authorFernández-Cidón, Bárbara
dc.contributor.authorCandás-Estébanez, Beatriz
dc.contributor.authorGil-Serret, Miriam
dc.contributor.authorAmigó, Núria
dc.contributor.authorCorbella, Emili
dc.contributor.authorRodríguez-Sánchez, M. Ángeles
dc.contributor.authorPadró-Miquel, Ariadna
dc.contributor.authorBrotons, Carlos
dc.contributor.authorHernández-Mijares, Antonio
dc.contributor.authorCalmarza, Pilar
dc.contributor.authorJarauta, Estibaliz
dc.contributor.authorBrea, Angel J.
dc.contributor.authorMauri, Marta
dc.contributor.authorGuijarro, Carlos
dc.contributor.authorVila, Àlex
dc.contributor.authorValdivielso, Pedro
dc.contributor.authorCorbella, Xavier
dc.contributor.authorPintó, Xavier
dc.contributor.authoraffiliation[Fernández-Cidón,B; Candás-Estébanez,B; Padró-Miquel,A] Bioquímica Especial y Biología Molecular, Laboratori Clínic, Hospital Universitario de Bellvitge, L’Hospitalet de Ll., Spain. [Candás-Estébanez,B] Clinical Laboratory, SCIAS-Hospital de Barcelona, Barcelona, Spain. [Gil-Serret,M; Amigó,N] Biosfer Teslab, Reus, Spain. [Amigó,N] CIBERDEM, Universidad Rovira i Virgili, Tarragona, Spain. [Corbella,E; Rodríguez-Sánchez,MA; Corbella,X; Pintó,X] Unidad de Lípidos y Riesgo Vascular, Servicio de Medicina Interna, Hospital Universitario de Bellvitge-IDIBELL, Barcelona, Spain. [Corbella,E; Pintó,X] Centro de Investigación Biomédica en Red, Fisiopatologia de la Obesidad y Nutrición CIBEROBN), Instituto de Salud Carlos III, Madrid, Spain. [Brotons,C] EAP Sardenya, Instituto de Investigaciones Biomédicas Sant Pau, Barcelona, Spain. [Hernández-Mijares,A] Hospital Universitario Dr. Peset, Valencia, Spain. [Calmarza,P; Jarauta,E] Servicio de Bioquímica Clínica, Hospital Universitario Miguel Servet, CIBERCV IIS Aragón, Universidad de Zaragoza, Zaragoza, Spain. [Brea,AJ] Hospital General San Pedro, Logroño, Spain. [Mauri,M] Hospital de Terrassa (Consorci Sanitari de Terrassa), Terrassa, Spain. [Guijarro,C] Departamento de Esepecialidades Médicas y Salud Pública, Unidad de Medicina Interna, Hospital Universitario Fundación Alcorcón, Universidad Rey Juan Carlos, Alcorcón, Spain. [Vila,A] Hospital de Figueres (Fundació Salut Empordà), Figueres, Spain. [Valdivielso,P] Hospital Universitario Virgen de la Victoria, IBIMA, Universidad de Málaga, Málaga, Spain. [Corbella,X] Facultad de Medicina y Ciencias de la Salud, Universitat Internacional de Catalunya, Barcelona, Spain. [Pintó,X] Department of Medicine, Campus Bellvitge, Universidad de Barcelona, L’Hospitalet de Ll., Spain.
dc.date.accessioned2024-02-19T15:26:40Z
dc.date.available2024-02-19T15:26:40Z
dc.date.issued2021-03-29
dc.description.abstractSome lipoprotein disorders related to the residual risk of premature cardiovascular disease (PCVD) are not detected by the conventional lipid profile. In this case-control study, the predictive power of PCVD of serum sdLDL-C, measured using a lipoprotein precipitation method, and of the physicochemical properties of serum lipoproteins, analyzed by nuclear magnetic resonance (NMR) techniques, were evaluated. We studied a group of patients with a first PCVD event (n = 125) and a group of control subjects (n = 190). Conventional lipid profile, the size and number of Very Low Density Lipoproteins (VLDL), Low Density Lipoproteins (LDL), High Density Lipoproteins (HDL) particles, and the number of particles of their subclasses (large, medium, and small) were measured. Compared to controls, PCVD patients had lower concentrations of all LDL particles, and smaller and larger diameter of LDL and HDL particles, respectively. PCVD patients also showed higher concentrations of small dense LDL-cholesterol (sdLDL), and triglycerides (Tg) in LDL and HDL particles (HDL-Tg), and higher concentrations of large VLDL particles. Multivariate logistic regression showed that sdLDL-C, HDL-Tg, and large concentrations of LDL particles were the most powerful predictors of PCVD. A strong relationship was observed between increased HDL-Tg concentrations and PCVD. This study demonstrates that beyond the conventional lipid profile, PCVD patients have other atherogenic lipoprotein alterations that are detected by magnetic resonance imaging (MRI) analysis.
dc.description.sponsorshipThis work was supported in part by the Spanish Ministry of Health (Carlos III Health Institute) through the Fondo de Investigación para la Salud (FIS), which is co-funded by the European Regional Development Fund, funded by the following grant codes: PI16/01094 and PI19/01032.
dc.identifier.doi10.3390/jcm10071379
dc.identifier.e-issn2077-0383es_ES
dc.identifier.journalJournal of Clinical Medicinees_ES
dc.identifier.otherhttp://hdl.handle.net/10668/4588
dc.identifier.pubmedID33805580es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/18297
dc.language.isoeng
dc.publisherMultidisciplinary Digital Publishing Institute (MDPI)
dc.relation.publisherversionhttps://www.mdpi.com/2077-0383/10/7/1379es
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectNMR analysis of lipoproteins
dc.subjectLipid profile
dc.subjectPremature cardiovascular disease
dc.subjectResidual cardiovascular risk
dc.subjectSmall dense LDL
dc.subjectLipoprotein particle number
dc.subjectLipoprotein precipitation
dc.subjectTriglycerides
dc.subjectAtherosclerosis
dc.subjectLípidos
dc.subjectEnfermedades cardiovasculares
dc.subjectFactores de riesgo de enfermedad cardiaca
dc.subjectLDL-colesterol
dc.subjectLipoproteínas
dc.subjectTriglycéridos
dc.subjectAterosclerosis
dc.subject.meshHumans
dc.subject.meshCholesterol, LDL
dc.subject.meshCardiovascular Diseases
dc.subject.meshCase-Control Studies
dc.subject.meshLogistic Models
dc.subject.meshTriglycerides
dc.subject.meshLipoproteins
dc.subject.meshLipoproteins, VLDL
dc.subject.meshArteriosclerosis
dc.subject.meshMagnetic Resonance Imaging
dc.titlePhysicochemical Properties of Lipoproteins Assessed by Nuclear Magnetic Resonance as a Predictor of Premature Cardiovascular Disease. PRESARV-SEA Study
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication
relation.isPublisherOfPublication30293a55-0e53-431f-ae8c-14ab01127be9
relation.isPublisherOfPublication.latestForDiscovery30293a55-0e53-431f-ae8c-14ab01127be9

Files